Private company

ProSomnus, Inc.

Last updated Oct 19, 2026.

Overview

IndustrySurgical & Medical Instruments & Apparatus¹
HeadquartersPleasanton, California¹
Business address5675 Gibraltar Dr, Pleasanton, Ca 94588²
Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company²
Legal formCorporation

See how the biggest companies compare on our leaderboards

We are a medical technology company focused on the development, manufacturing and marketing of precision intraoral medical devices, a novel non-invasive option for treating and managing patients with obstructive sleep apnea (OSA). Each ProSomnus precision intraoral device is personalized based on the anatomy and treatment plan for each patient. Our patented precision devices are engineered to create unique, consistent and predictable biomechanical advantages that lead to effective, comfortable, economical and patient preferred treatment outcomes for patients with OSA.³ From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-69.1%Operating margin⁴

-87.1%Net margin⁴

42.6%Revenue growth, 2023⁴

-$17.6MFree cash flow⁴

Where the money goes

Where each dollar of revenue went, fiscal 2023

Cost of revenueResearch and developmentOther costsInterest

Cost of revenue49¢$13.6M
Research and development17¢$4.8M
Other costs14¢$3.8M
Interest19¢$5.4M

Out of $27.7M in revenue.⁴ The company lost money this year.

Financial statements

Revenue⁵⁴$27.7M in 2023+96% since 2021

Gross profit⁵$10.3M in 2022+40% since 2021

Operating income⁵⁴-$19.1M in 2023+296% since 2021

Net income⁵⁴-$24.1M in 2023+303% since 2021

Fiscal year	2021	2022	2023
Revenue	$14.1M⁵	$19.4M⁴	$27.7M⁴
Cost of revenue	$6.8M⁵	$9.1M⁴	$13.6M⁴
Gross profit	$7.3M⁵	$10.3M⁵
Research and development	$1.9M⁵	$3.0M⁴	$4.8M⁴
Operating expenses	$12.1M⁵	$21.7M⁵	$46.8M⁴
Operating income	-$4.8M⁵	-$11.5M⁴	-$19.1M⁴
Interest	$3.2M⁵	$6.1M⁴	$5.4M⁴
Income before tax	-$6.0M⁵	-$7.1M⁵
Income tax		$0⁴	$0⁴
Net income	-$6.0M⁵	-$7.1M⁴	-$24.1M⁴
Earnings per share	-$1.51⁵	-$0.71⁴	-$1.49⁴
Earnings per share (diluted)	-$1.51⁵	-$0.71⁴	-$1.49⁴
Shares (weighted, basic)	4.0M shares⁵	10.0M shares⁴	16.2M shares⁴
Shares (weighted, diluted)	4.0M shares⁵	10.0M shares⁴	16.2M shares⁴

Total assets⁵⁴$26.3M in 2023+244% since 2021

Total liabilities⁵⁴$52.9M in 2023+138% since 2021

Shareholders’ equity⁵⁴-$38.2M in 2023−19% since 2020

Cash⁵⁴$6.4M in 2023+309% since 2020

Long-term debt⁵⁴$129.0K in 2023−31% since 2022

Fiscal year	2020	2021	2022	2023
Cash	$1.6M⁵	$1.5M⁵	$15.9M⁴	$6.4M⁴
Receivables		$2.1M⁵	$2.8M⁴	$3.8M⁴
Inventory		$378.8K⁵	$640.0K⁴	$2.0M⁴
Current assets		$4.1M⁵	$21.2M⁴	$14.3M⁴
Property, plant and equipment		$3.4M⁵	$2.4M⁴	$3.4M⁴
Total assets		$7.6M⁵	$33.2M⁴	$26.3M⁴
Accounts payable		$955.6K⁵	$2.1M⁴	$4.0M⁴
Short-term debt			$59.0K⁵	$57.0K⁴
Current liabilities		$6.6M⁵	$7.1M⁴	$14.3M⁴
Long-term debt			$185.6K⁵	$129.0K⁴
Long-term liabilities		$15.7M⁵	$46.6M⁵
Total liabilities		$22.2M⁵	$53.7M⁴	$52.9M⁴
Retained earnings		-$203.6M⁵	-$210.8M⁴	-$234.9M⁴
Shareholders’ equity	-$47.2M⁵	-$53.2M⁴	-$20.5M⁴	-$38.2M⁴
Shares outstanding		24.6M shares⁵	16.0M shares⁴	17.4M shares⁴

Cash from operations⁵⁴-$16.1M in 2023+248% since 2021

Capital spending⁵⁴$1.5M in 2023+387% since 2021

Free cash flow⁵⁴-$17.6M in 2023+256% since 2021

Fiscal year	2021	2022	2023
Cash from operations	-$4.6M⁵	-$10.2M⁴	-$16.1M⁴
Stock-based compensation	$4.7K⁵	$2.2M⁴	$1.2M⁴
Capital spending	$301.3K⁵	$1.4M⁴	$1.5M⁴
Free cash flow	-$4.9M	-$11.6M	-$17.6M
Cash from investing	-$301.3K⁵	-$1.4M⁴	-$1.5M⁴
Cash from financing	$4.9M⁵	$26.0M⁴	$8.7M⁴
Dividend per share			$0.00⁴

Compare ProSomnus, Inc. with another company

Leadership

Who has led ProSomnus, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

Len Liptak2022–2024

Chief financial officer

2025

Chief executive officerLen Liptak Dec 6, 2022 to Feb 16, 2024⁸
Chief financial officerBrian B. Dow Mar 10, 2023 to Feb 16, 2024⁹
Chief financial officerMelinda Hungerman Dec 6, 2022 to Feb 2, 2023¹⁰

Board members and other officers (6)

Chief Growth OfficerMark Thomas Murphy Apr 11, 2023 to Apr 11, 2023¹¹
Board memberJason Orchard Dec 6, 2022 to Feb 2, 2023¹²
Board memberLen Liptak Dec 6, 2022 to Feb 16, 2024⁸
Board memberLeonard Hedge Dec 6, 2022 to Feb 2, 2023¹³
Board memberLaing Rikkers Dec 7, 2022 to Feb 16, 2024¹⁴
Board memberSteven Robert Pacelli Dec 7, 2022 to Feb 16, 2024¹⁵

Named in SEC Form D filings

People the company listed in its private-offering notices.

Executive Officer, DirectorLeonard Liptak named Oct 2, 2023¹⁶
Executive OfficerSung Kim named Oct 2, 2023¹⁶
DirectorHeather Rider named Oct 2, 2023¹⁶
DirectorWilliam Johnson named Oct 2, 2023¹⁶

Former names

LAAA Merger Corp.Jun 29, 2022 to Nov 15, 2022²

Timeline

Dec 6, 2022New chief executive Len Liptak becomes CEO⁸

Filings

159 filings to the SEC since October 2021: 3 annual reports, 5 quarterly reports, 34 major events, 38 insider forms, 8 large holders, 1 private raises, 70 other. The latest 20:

Nov 13, 2024SC 13G/A EDGAR
Aug 7, 2024EFFECT EDGAR
Aug 7, 2024EFFECT EDGAR
Aug 5, 202415-12G EDGAR
Aug 2, 2024S-8 POS EDGAR
Aug 2, 2024S-8 POS EDGAR
Aug 2, 2024POS AM EDGAR
Aug 2, 2024POS AM EDGAR
Jul 31, 202410-Q EDGAR
Jul 31, 20248-K EDGAR
Jun 27, 20248-K EDGAR
Jun 6, 20248-K EDGAR
May 20, 202410-Q EDGAR
May 16, 20248-K EDGAR
May 15, 2024NT 10-Q EDGAR
May 8, 20248-K EDGAR
Apr 30, 20248-K EDGAR
Apr 29, 202410-K/A EDGAR
Apr 19, 20248-K EDGAR
Apr 18, 20248-K EDGAR

The 159 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Walleye Capital LLCSC 13G/A, 2 filings Feb 14, 2024 to Nov 13, 2024¹⁷
Polar Asset Management Partners Inc.SC 13G/A, 3 filings Feb 14, 2023 to Feb 12, 2024¹⁸
SMC Holdings II, LPSC 13D/A, 2 filings Oct 23, 2023 to Dec 8, 2023¹⁹
HealthpointCapital Partners LPSC 13D, 1 filing Dec 16, 2022²⁰

Money raised

Private offerings the company reported to the SEC on Form D.

Sep 20, 2023Raised $10.1 million in a private offering of securities Form D: $25 million offered in all Form D

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARProSomnus, Inc. filings on SEC EDGAR
2
SEC EDGARProSomnus, Inc. filings on SEC EDGAR
3
SEC EDGARProSomnus, Inc. annual report, Item 1 (Business)
4
SEC EDGARProSomnus, Inc. 10-K for fiscal 2023
5
SEC EDGARProSomnus, Inc. 10-K for fiscal 2021
6
SEC EDGARProSomnus, Inc. 10-Q for fiscal 2024
7
SEC EDGARProSomnus, Inc. 10-Q for fiscal 2024
8
SEC EDGARLen Liptak, Chief executive officer
9
SEC EDGARBrian B. Dow, Chief financial officer
10
SEC EDGARMelinda Hungerman, Chief financial officer
11
SEC EDGARMark Thomas Murphy, Chief Growth Officer
12
SEC EDGARJason Orchard, Board member
13
SEC EDGARLeonard Hedge, Board member
14
SEC EDGARLaing Rikkers, Board member
15
SEC EDGARSteven Robert Pacelli, Board member
16
SEC EDGARProSomnus, Inc. Form D naming Leonard Liptak
17
SEC EDGARWalleye Capital LLC SC 13G/A on ProSomnus, Inc.
18
SEC EDGARPolar Asset Management Partners Inc. SC 13G/A on ProSomnus, Inc.
19
SEC EDGARSMC Holdings II, LP SC 13D/A on ProSomnus, Inc.
20
SEC EDGARHealthpointCapital Partners LP SC 13D on ProSomnus, Inc.